APA (7th ed.) Citation

LD, Z., MM, N., SM, O., NB, H., AM, P., AO, O., . . . AG, R. (2023). BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3), e90. https://doi.org/10.1093/cid/ciac637

Chicago Style (17th ed.) Citation

LD, Zambrano, et al. "BNT162b2 MRNA Vaccination Against Coronavirus Disease 2019 Is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76, no. 3 (2023): e90. https://doi.org/10.1093/cid/ciac637.

MLA (9th ed.) Citation

LD, Zambrano, et al. "BNT162b2 MRNA Vaccination Against Coronavirus Disease 2019 Is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 3, 2023, p. e90, https://doi.org/10.1093/cid/ciac637.